share_log

Sunzen Biotech Invests RM4m in Farmer International for Health Collaboration

The Malaysian Reserve ·  Jan 28 19:06

Sunzen Biotech Bhd's subsidiary, Ecolite Biotech Sdn Bhd, has enters Subscription Agreement for Strategic Investment in Farmer International Holdings, Paving the Way for Innovative Collaborations in Health and Wellness Sector"

Sunzen Biotech Bhd's subsidiary, Ecolite Biotech Manufacturing Sdn Bhd, has entered into a subscription agreement with Farmer International Holdings Sdn Bhd (FIHSB) and its existing shareholders for the proposed subscription of 100,000 new ordinary shares.

This strategic investment, totaling RM4.32 million, aims to facilitate collaborative efforts in the health and wellness sector.

FIHSB, incorporated in April 2023, is an investment holding company with three wholly-owned subsidiaries: Herbal Farmer Retail Sdn Bhd, BHH Products Sdn Bhd, and Sensei Yo Integrated Sdn Bhd. Herbal Farmer, a recognised brand with modernised healthcare offerings, operates in key shopping malls across Kuala Lumpur, Johor, and Penang.

As part of the agreement, FIHSB and its existing shareholders provide a profit guarantee, committing to a minimum after-tax profit of RM9.6 million for the financial years 2024 to 2026.

Ecolite, as a shareholder of FIHSB, is guaranteed a minimum order commitment, fostering a mutually beneficial relationship.

Sunzen's group MD, Teo Yek Ming, noted the shared vision of providing consumers with healthier, natural, and high-quality products.

The collaboration combines Herbal Farmer's innovative retail model with Ecolite's scientific research and manufacturing expertise, positioning them for significant growth.

The collaboration is seen as a strategic move by Sunzen to optimise its product supply chain, achieve more efficient production, and enhance overall competitiveness in the health and wellness market.

Retaining individual brand identities, Ecolite and Herbal Farmer aim to create a powerful synergy, expanding market share and redefining industry standards.

Its board anticipates positive outcomes and benefits for Sunzen Biotech through this dynamic collaboration.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment